A 20‐Year Epidemiological Study of Pneumococcal Meningitis
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
We conducted a retrospective analysis of 55 community-acquired Streptococcus pneumoniae meningitis illnesses in Huntington, West Virginia, from 1978 to 1997. Fourteen (36.8%) of 38 adults and 2 (11.8%) of 17 children died. Serotypes 6, 23, 3, and 18 accounted for 20 (41.7%) of 48 strains available for serotyping. Of 40 strains available for antimicrobial susceptibility testing, 1 serotype 19 and 1 serotype 23 strain showed intermediate resistance and a second serotype 23 strain showed high resistance to penicillin; all three patients survived. The case-fatality rates among adults who received penicillin alone, gentamicin in combination, or vancomycin and cephalosporin together were 57.1%, 55.5%, and 60%, respectively, and among those who received chloramphenicol or a third-generation cephalosporin, they were 11.1% or nil, respectively. No child died who received chloramphenicol or vancomycin. Two (33%) of 6 children died who received a third-generation cephalosporin; both were critically ill when initially treated. No child and one adult had received pneumococcal vaccine prior to becoming ill.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite reported successes, there has been a report of cases of invasive H. influenzae type b disease in children previously vaccinated in Nottingham, United Kingdom (117), perhaps because in the United Kingdom, children are vaccinated at 2, 3, and 4 months of age without the administration of a booster dose (295).”
From Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis (2010) · cites this paper as [295]
Citations
Cites
Acute Bacterial Meningitis in Adults -- A Review of 493 Episodes
Durand, M. L., Calderwood, S. B., Weber, D. J., Miller, S. I., Southwick, F. S., Caviness, V. S., & Swartz, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280104 · Cited by 1,344 · cited 2×
“Age, an impaired level of consciousness, and seizures within the first 24 hours proved the most important prognostic factors [28].”
BackgroundOutcomes of bacterial meningitis in children: a meta-analysis
BARAFF, L. J., LEE, S. I., & SCHRIGER, D. L. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199305000-00008 · Cited by 495 · cited 4×
“These case-fatality rates do not differ from those in other industrialized populations [27-29].”
BackgroundInfluentialDoern, G. V., Brueggemann, A., Holley, H. P., & Rauch, A. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1208 · Cited by 482 · cited 1×
“resistant strains emerged also during this time period, including strains that exhibited resistance to the cephalosporin class of antibiotics [21, 40-44].”
BackgroundRennels, M. B., Edwards, K. M., Keyserling, H. L., Reisinger, K. S., Hogerman, D. A., Madore, D. V., Chang, I., Paradiso, P. R., Malinoski, F. J., & Kimura, A. (1998) · Pediatrics · doi:10.1542/peds.101.4.604 · Cited by 392 · cited 1×
“A protein conjugate vaccine currently under development appears to be highly antigenic in infants and children [50-55].”
BackgroundCost-effectiveness of Vaccination Against Pneumococcal Bacteremia Among Elderly People
Sisk, J. E. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160053038 · Cited by 362 · cited 1×
“It continues to be underused even though the cost benefit of he vaccine has been well established [49].”
BackgroundKlugman, K. P., Friedland, I. R., & Bradley, J. S. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.1988 · Cited by 240
Davidson, M., Parkinson, A. J., Bulkow, L. R., Fitzgerald, M. A., Peters, H., & Parks, D. J. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.2.368 · Cited by 231 · cited 2×
“incidence was 84 cases/100,000 [32].”
BackgroundClavo‐Sanchez, A. J., Giron‐Gonzalez, J. A., Lopez‐Prieto, D., Canueto‐Quintero, J., Sanchez‐Porto, A., Vergara‐Campos, A., Marin‐Casanova, P., & Cordoba‐Dona, J. A. (1997) · Clinical Infectious Diseases · doi:10.1086/513628 · Cited by 172
Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci
Viladrich, P. F., Gudiol, F., Liñares, J., Rufi, G., Ariza, J., & Pallarés, R. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90061-7 · Cited by 155 · cited 1×
“With the worldwide emergence of penicillin-nonsusceptible (resistant) pneumococci over the last several years, treatment regimens now include the cephalosporin class of antibiotics and vancomycin [11-13].”
BackgroundOutcomes of bacterial miningitis in children: A meta-analysis
Paik, L. (1993) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)81289-2 · Cited by 149
Research works printed but not linked: 3
- Kirkpatrick B, 1994, J Clin Microbiol, 32, 63
- Urwin G, 1991, J Clin Microbiol, 29, 14
- Rasmussen HH, 1994, Israel. Isr J Med Sci, 30, 5
Cited by
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930
“Gram staining correctly identifies the pathogen in 69 to 93% of patients with pneumococcal meningitis (11, 15, 49, 68, 95, 148, 208, 242, 286, 294, 340).”
BackgroundKastenbauer, S., & Pfister, H.-W. (2003) · Brain · doi:10.1093/brain/awg113 · Cited by 482
Pathogenesis and pathophysiology of pneumococcal meningitis
Koedel, U., Scheld, W. M., & Pfister, H.-W. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00450-4 · Cited by 380
Weisfelt, M., van de Beek, D., Spanjaard, L., Reitsma, J. B., & de Gans, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70288-x · Cited by 313
Bacteremic and Nonbacteremic Pneumococcal Pneumonia A Prospective Study
Musher, D. M., Alexandraki, I., Graviss, E. A., Yanbeiy, N., Eid, A., Inderias, L. A., Phan, H. M., & Solomon, E. (2000) · Medicine · doi:10.1097/00005792-200007000-00002 · Cited by 217
Review: Pathophysiology and treatment of bacterial meningitis
Hoffman, O., & Weber, J. R. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609337975 · Cited by 179
“An emerging problem is the growing prevalence of pneumococci resistant to beta-lactam antibiotics [Stanek and Mufson, 1999].”
BackgroundNigrovic, L. E., Kuppermann, N., & Malley, R. (2002) · Pediatrics · doi:10.1542/peds.110.4.712 · Cited by 173
Serotype-specific mortality from invasive Streptococcus pneumoniaedisease revisited
Martens, P., Worm, S. W., Lundgren, B., Konradsen, H. B., & Benfield, T. (2004) · BMC Infectious Diseases · doi:10.1186/1471-2334-4-21 · Cited by 158
“Mortality associated with invasive disease remains high at 5– 35% depending on site of infection, age and comorbidity [1-4].”
BackgroundPneumococcal meningitis in adults: new approaches to management and prevention
Weisfelt, M., de Gans, J., van der Poll, T., & van de Beek, D. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70409-4 · Cited by 153
Flores-Cordero, J. M., Amaya‐Villar, R., Rincón-Ferrari, M. D., Leal-Noval, S. R., Garnacho‐Montero, J., Llanos-Rodríguez, A. C., & Murillo-Cabezas, F. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1935-4 · Cited by 112
“Pneumococcal meningitis remains a disease that carries high mortality and morbidity rates [13, 23, 24, 25].”
Backgroundvan Ettekoven, C. N., Liechti, F. D., Brouwer, M. C., Bijlsma, M. W., & van de Beek, D. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.24802 · Cited by 81
Vincent, J., Nadel, S., Kutsogiannis, D. J., Gibney, R. T. N., Yan, S.-C. B., Wyss, V. L., Bailey, J., Mitchell, C. L., Sarwat, S., Shinall, S. M., et al. (2005) · Critical Care · doi:10.1186/cc3538 · Cited by 75
“For children, mortality rates for MEN tend to be closer to 10% but have been reported to be 21% for those also presenting with shock [37,41,43].”
BackgroundOligbu, G., Collins, S., Djennad, A., Sheppard, C. L., Fry, N. K., Andrews, N. J., Borrow, R., Ramsay, M. E., & Ladhani, S. N. (2019) · Emerging infectious diseases · doi:10.3201/eid2509.180747 · Cited by 64
Early Vancomycin Therapy and Adverse Outcomes in Children With Pneumococcal Meningitis
Buckingham, S. C., McCullers, J. A., Luján‐Zilbermann, J., Knapp, K. M., Orman, K. L., & English, B. K. (2006) · PEDIATRICS · doi:10.1542/peds.2005-2282 · Cited by 44
“Age, median (IQR), mo 10 (5–20) Female gender, % 45/114 (39) Ethnicity, n/N (%) Black 74/114 (65) White 40/114 (35) Admission year 1991–1996 63/114 (55) 1997–2001 51/114 (45) Transferred from outside institution, n/N (%) 27/114 (24) Underlying medical condition, n/N (%) 23/114 (20) Seizures before presentation, n/N (%…”
Pneumococcal polysaccharide vaccines
Jackson, L. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00033-1 · Cited by 47
Imöhl, M., Møller, J. K., Reinert, R. R., Perniciaro, S., van der Linden, M., & Aktaş, O. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0787-1 · Cited by 44
“Case fatality rates in pneumococcal meningitis are high, ranging from 10% up to 60%, and are higher in adults than in children [6].”
BackgroundTrends and geographical variation in invasive pneumococcal infections in Finland
Klemets, P., Lyytikäinen, O., Ruutu, P., Kaijalainen, T., Leinonen, M., Ollgren, J. P., & Nuorti, J. P. (2008) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540801938931 · Cited by 32
“The incidence of pneumococcal meningitis was highest in childrenB1 y of age and the age-specific rates were similar to those found in other studies from developed countries [19,20].”
ResultClinical Features of Patients With Recurrent Invasive Streptococcus pneumoniae Disease
Mufson, M. A., Hao, J. B., Stanek, R. J., & Norton, N. B. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31822d9860 · Cited by 30
Self-citationEinarsdóttir, H., Erlendsdóttir, H., Kristinsson, K. G., & Gottfreðsson, M. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01221.x · Cited by 30
“Infections caused by Streptococcus pneumoniae are common, and invasive infections, such as bacteraemia and meningitis, caused by this organism are associated with high rates of morbidity and mortality [1,2].”
Doit, C., Picard, B., Loukil, C., Geslin, P., & Bingen, É. (2000) · The Journal of Infectious Diseases · doi:10.1086/315502 · Cited by 30
“The yearly estimated incidence of pneumococcal meningitis is 1–2 cases per 100,000 inhabitants in industrialized countries [20] and >50 cases per 100,000 inhabitants in developing countries [21].”
BackgroundTreatment of bacterial meningitis
Tunkel, A. R., & Scheld, W. M. (2002) · Current Infectious Disease Reports · doi:10.1007/s11908-002-0062-7 · Cited by 27
“In one retrospective analysis of 55 cases of community-acquired meningitis caused by S. pneumoniae [ 32 ], the case-fatality rates among adults were lower if treatment included chloramphenicol or a third-generation cephalosporin; however, the number of patients receiving differing antimicrobial regimens was very small…”
Acacetin inhibits Streptococcus pneumoniae virulence by targeting pneumolysin
Li, S., Lv, Q., Sun, X., Tang, T., Deng, X., Yin, Y., & Li, L. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13279 · Cited by 26
“Invasive infections of the bacterium continue to be a major cause of morbidity and mortality worldwide.([4]) S.”
BackgroundCost-Effectiveness of the Pneumococcal Vaccine in Healthy Younger Adults
Pepper, P. V., & Owens, D. K. (2002) · Medical Decision Making · doi:10.1177/027298902237705 · Cited by 26
Ghia, C. J., & Rambhad, G. S. (2021) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361211046453 · Cited by 25
Mufson, M. A., Chan, G., & Stanek, R. J. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3180312cd5 · Cited by 23
Self-citationDecline in the incidence of invasive pneumococcal disease at a medical center in Taiwan, 2000–2012
Lai, C., Lin, S., Liao, C., Sheng, W., & Hsueh, P. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-76 · Cited by 20
Bactériologie des méningites communautaires dans la région de Sfax, Tunisie (1993-2001)
Maâlej, S., Kassis, M., Rhimi, F., Dammak, J., & Hammami, A. (2006) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2005.10.011 · Cited by 18
Domon, H., Maekawa, T., Yonezawa, D., Nagai, K., Oda, M., Yanagihara, K., & Terao, Y. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00161-18 · Cited by 17
“Invasive infections by this bacterium continue to be a principal cause of morbidity and mortality worldwide (1, 2).”
BackgroundEpidemiology of invasive pneumococcal disease and vaccine provision in a tertiary referral center
Rock, C., Sadlier, C., Fitzgerald, J., Kelleher, M., Dowling, C., Kelly, S., & Bergin, C. J. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1859-z · Cited by 16
Thabet, F. C., Tilouche, S., Tabarki, B. M., Amri, F., Guediche, M. N., Sfar, M. T., Harbi, A., Yacoub, M., & Essoussi, A. S. (2006) · Archives de Pédiatrie · doi:10.1016/j.arcped.2006.11.012 · Cited by 16
Treatment of bacterial meningitis
Hasbun, R., Aronin, S. I., & Quagliarello, V. (1999) · Comprehensive Therapy · doi:10.1007/bf02889599 · Cited by 16
A 32-Year Study of the Effect of Pneumococcal Vaccines on Invasive Streptococcus pneumoniae Disease
Stanek, R. J., Norton, N. B., & Mufson, M. A. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2016.09.002 · Cited by 15
“In this retrospective investigation of IPD spanning 32 years from 1983-2014, consecutive pneumococcal isolates were obtained from 1,196 inpatients at St. Mary's Medical Center and Cabell Huntington Hospital (adults and children) and at the Veterans Administration Medical Center-Huntington (adults), all affiliated with…”
BackgroundMethodSelf-citationHaddad, P. A., Repka, T. L., & Weisdorf, D. J. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01154-3 · Cited by 15
The pneumococcal protein conjugate vaccines
Peters, T. R., & Edwards, K. M. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.109114 · Cited by 14
Limitations of beta-lactam therapy for infections caused by susceptible Gram-positive bacteria
English, B. K. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.07.010 · Cited by 13
Pneumococcal polysaccharide vaccines
Jackson, L. A., & Neuzil, K. M. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50028-3 · Cited by 22
Pneumococcal Antibiotic Resistance and Rates of Meningitis in Children
Ryan, M. W., & Antonelli, P. J. (2000) · The Laryngoscope · doi:10.1097/00005537-200006000-00014 · Cited by 13
“low rates of meningitis attributable to resistant pneumococcus.(9) As recently as 1995, Chesney et al.”
BackgroundHeadache attributed to infections
Marchioni, E., & Minoli, L. (2010) · Handbook of clinical neurology · doi:10.1016/s0072-9752(10)97052-8 · Cited by 14
Baker, C. I., Barrozo, C. P., Ryan, M. A. K., Pearse, L. A., & Russell, K. L. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-38 · Cited by 10
“to reveal PS38 among the reported contributing serotypes [1,10].”
BackgroundStanek, R. J., Mufson, M. A., & Norton, N. B. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182517785 · Cited by 9
Self-citationPathogenesis of Pneumococcal Meningitis
Weber, J. R. (2014) · ASM Press eBooks · doi:10.1128/9781555816537.ch16 · Cited by 8
Pneumococcal meningitis in Iran: a systematic review and meta–analysis
Nasiri, M. J., Tabatabaei, S. R., Shamshiri, A. R., Weinberger, D. M., Dadashi, M., & Karimi, A. (2019) · Journal of Acute Disease · doi:10.4103/2221-6189.259108 · Cited by 7
“Pneumococcus causes 10% to 60% of meningitis cases among patients in different age groups, but the incidence is higher in adults patients than in children[5,6].”
BackgroundEmergence of a Unique Penicillin-Resistant Streptococcus pneumoniae Serogroup 35 Strain
Stanek, R. J., Maher, M. B., Norton, N. B., & Mufson, M. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01620-10 · Cited by 6
“pneumoniae is the predominant bacterial pathogen of community-acquired pneumonia and a major cause of meningitis and of otitis media in children (1, 2, 8, 9, 17, 20, 22, 23, 26, 27, 32, 33, 35, 37).”
BackgroundSelf-citationDifferences in the courses of meningococcal and pneumococcal cerebrospinal meningitis
Szymański, W., Simon, K. A., & Rorat, M. (2020) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2020.0002 · Cited by 5
Epidemiology, Diagnosis, and Treatment of Serious Pneumococcal Infections in Children
Madhi, S. A., & Pelton, S. I. (2014) · ASM Press eBooks · doi:10.1128/9781555815820.ch8 · Cited by 6
Pneumococcal Vaccines: Present and Future
Peters, T. R., & Edwards, K. M. (2002) · Pediatric Annals · doi:10.3928/0090-4481-20020401-10 · Cited by 4
Observatoire Rhône-Alpes du pneumocoque en 1999 : 35 cas de méningites
Chomarat, M., Frédénucci, I., Barbé, G., Boucaud-Maître, Y., Boyer, M., Carricajo, A., Célard, M., Clergeau, P., Croizé, J., Delubac, F., et al. (2002) · Pathologie Biologie · doi:10.1016/s0369-8114(02)00356-5 · Cited by 4
Predisposing Factors Responsible for the Occurrence of Bacterial Purulent Meningoencephalitis
Dupanović, B. (2017) · Acta Clinica Croatica · doi:10.20471/acc.2017.56.01.17 · Cited by 2
État de la résistance du pneumocoque en 1999 dans la région Rhône-Alpes
Frédénucci, I., Chomarat, M., Barbé, G., Boucaud-Maître, Y., Boyer, M., Carricajo, A., Célard, M., Clergeau, P., Croizé, J., Delubac, F., et al. (2001) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(01)00193-7 · Cited by 2
Pelton, S. I., Yildirim, I. B., Olarte, L., & Hultén, K. G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00085-6 · Cited by 1
Klemets, P. (2009) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 1
Genomic diversity in naturally transformable Streptococcus pneumoniae
Inverarity, D. (2009) · Enlighten: Theses (The University of Glasgow)
Frédénucci, I., Chomarat, M., Barbé, G., Boucaud-Maître, Y., Boyer, M., Carricajo, A., Célard, M., Clergeau, P., Croizé, J., Delubac, F., et al. (2001) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(01)00194-9
Kari, S. (2003)
Ricketson, L. J. (2012) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/21185
Acute Pediatric Central Nervous System Infections
Harmon, W. G., Maffei, F. A., & Rubenstein, J. S. (2006) · Elsevier eBooks · doi:10.1016/b978-032301808-1.50060-2
Bacterial meningitis in children : clinical aspects and preventive effects of vaccinations
Kostenniemi, U. J. (2020)
Prospects of Single Cell Omics (SCO) Analysis for Investigating Nervous System Disorders
Khan, M. Q., & Bakhtiar, S. M. (2022) · Current Trends in OMICS · doi:10.32350/cto.21.03
“Although, the use of conjugate pneumococcal vaccines has reduced meningitis [53], still resistance against the beta-lactam antibiotic has increased its prevalence [54].”
Background
Metadata
- Authors
- Stanek, R. J., & Mufson, M. A.
- Affiliations
- Marshall University (US)
- Corresponding author
- Mufson, Maurice A.
- ORCID
- Mufson, Maurice A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-06
- Volume
- 28
- Issue
- 6
- Pages
- 1265-1272
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2137414109
- Cited by
- 59
- References
- 55
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 2
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- pneumococcal meningitis, Streptococcus pneumoniae, community-acquired meningitis, case fatality rate, serotypes, antimicrobial resistance, penicillin resistance, vancomycin, gentamicin, chloramphenicol, third-generation cephalosporins, pneumococcal vaccine, children, adults
- MeSH terms
- Adolescent, Adult, Aged, Bacterial Vaccines, Cerebrospinal Fluid Proteins, Child, Child, Preschool, Humans, Infant, Infant, Newborn, Meningitis, Pneumococcal, Microbial Sensitivity Tests, Middle Aged, Streptococcus pneumoniae, Time Factors, Incidence, Pneumococcal Vaccines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.